Andrographolide prevents human breast cancer-induced osteoclastic bone loss via attenuated RANKL signaling. (Q39028702)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24481680%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

title

Andrographolide prevents human breast cancer-induced osteoclastic bone loss via attenuated RANKL signaling (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24481680%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24481680%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Tingting Tang

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24481680%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

9

Kerong Dai

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24481680%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

1

Zanjing Zhai

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24481680%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Guangwang Liu

5

object named as

Guangwang Liu

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24481680%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

author name string

Wei Yan

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24481680%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Haowei Li

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24481680%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Xuqiang Liu

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24481680%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

An Qin

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24481680%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

language of work or name

English

0 references

publication date

31 January 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24481680%20AND%20SRC:MED&resulttype=core&format=json

Breast Cancer Research and Treatment

6 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24481680%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

volume

144

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24481680%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24481680%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

page(s)

33-45

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24481680%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s10549-014-2844-7

6 March 2020

exact match

0 references

cites work

Metastatic bone disease: clinical features, pathophysiology and treatment strategies

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2844-7

Mechanisms of bone metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2844-7

Molecular mechanisms of osteolytic bone metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2844-7

Metastasis to bone: causes, consequences and therapeutic opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2844-7

RANK ligand as a therapeutic target for bone metastases and multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2844-7

Evidence of a role for RANKL in the development of myeloma bone disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2844-7

Prostate cancer bone metastases promote both osteolytic and osteoblastic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2844-7

Osteoclast differentiation and activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2844-7

RANKing intracellular signaling in osteoclasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2844-7

Efficacy and safety of denosumab for the treatment of bone metastases in patients with advanced cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2844-7

Denosumab for the treatment of cancer therapy-induced bone loss and prevention of skeletal-related events in patients with solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2844-7

Progress in the treatment of bone metastases in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2844-7

Management of bone metastases in refractory prostate cancer--role of denosumab

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2844-7

Andrographis paniculata in the treatment of upper respiratory tract infections: a systematic review of safety and efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2844-7

Recent advances in plant hepatoprotectives: a chemical and biological profile of some important leads.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2844-7

Immunostimulant agents from Andrographis paniculata.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2844-7

Andrographolide, a potential cancer therapeutic agent isolated from Andrographis paniculata

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2844-7

Andrographolide inhibits oral squamous cell carcinogenesis through NF-κB inactivation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2844-7

Andrographolide suppresses the expression of inducible nitric oxide synthase in macrophage and restores the vasoconstriction in rat aorta treated with lipopolysaccharide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2844-7

Andrographolide prevents oxygen radical production by human neutrophils: possible mechanism(s) involved in its anti-inflammatory effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2844-7

Potency of andrographolide as an antitumor compound in BHC-induced liver damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2844-7

Synthesis and evaluation of antibacterial activities of andrographolide analogues

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2844-7

MCF10DCIS.com xenograft model of human comedo ductal carcinoma in situ.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2844-7

Ocimum gratissimum retards breast cancer growth and progression and is a natural inhibitor of matrix metalloproteases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2844-7

Inhibition of breast tumor growth and angiogenesis by a medicinal herb: Ocimum gratissimum

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2844-7

Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2844-7

Prevention of wear particle-induced osteolysis by a novel V-ATPase inhibitor saliphenylhalamide through inhibition of osteoclast bone resorption

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2844-7

12-O-tetradecanoylphorbol-13-acetate (TPA) inhibits osteoclastogenesis by suppressing RANKL-induced NF-kappaB activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2844-7

Amyloid beta-peptide stimulates nitric oxide production in astrocytes through an NFkappaB-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2844-7

Glucocorticoids suppress tumor necrosis factor-alpha expression by human monocytic THP-1 cells by suppressing transactivation through adjacent NF-kappa B and c-Jun-activating transcription factor-2 binding sites in the promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2844-7

Particle-induced osteolysis in three-dimensional micro-computed tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2844-7

Requirement for NF-kappaB in osteoclast and B-cell development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2844-7

NF-kappaB functions in osteoclasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2844-7

A cytokine-responsive IkappaB kinase that activates the transcription factor NF-kappaB

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2844-7

Regulation of the transcriptional activity of c-Fos by ERK. A novel role for the prolyl isomerase PIN1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2844-7

Mangiferin attenuates osteoclastogenesis, bone resorption, and RANKL-induced activation of NF-κB and ERK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2844-7

Suppression of osteoclastogenesis by N,N-dimethyl-D-erythro-sphingosine: a sphingosine kinase inhibition-independent action.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2844-7

Critical roles of c-Jun signaling in regulation of NFAT family and RANKL-regulated osteoclast differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2844-7

Epigallocatechin-3-gallate inhibits osteoclastogenesis by down-regulating c-Fos expression and suppressing the nuclear factor-kappaB signal

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2844-7

The phosphatidylinositol 3-kinase, p38, and extracellular signal-regulated kinase pathways are involved in osteoclast differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2844-7

NF-kappaB at the crossroads of life and death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2844-7

To be, or not to be: NF-kappaB is the answer--role of Rel/NF-kappaB in the regulation of apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2844-7

Activators and target genes of Rel/NF-kappaB transcription factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2844-7

Anti-dengue virus nonstructural protein 1 antibodies cause NO-mediated endothelial cell apoptosis via ceramide-regulated glycogen synthase kinase-3β and NF-κB activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2844-7

The Bcl2 family: regulators of the cellular life-or-death switch

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2844-7

Emerging roles of caspase-3 in apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2844-7

The Caenorhabditis elegans cell-death protein CED-3 is a cysteine protease with substrate specificities similar to those of the human CPP32 protease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2844-7

Clinical course and prognostic factors following bone recurrence from breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2844-7

Effect of bisphosphonates on pain and quality of life in patients with bone metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2844-7

Calcitonin for the long-term prevention and treatment of postmenopausal osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2844-7

Therapeutic approaches to bone diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2844-7

Bisphosphonate treatment of osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2844-7

Bisphosphonate-induced necrosis of the jaws: a reconstructive nightmare

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2844-7

Inhibition of RANKL increases the anti-tumor effect of the EGFR inhibitor panitumumab in a murine model of bone metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2844-7

Inhibition of RANKL blocks skeletal tumor progression and improves survival in a mouse model of breast cancer bone metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2844-7

Genetic regulation of osteoclast development and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2844-7

Osteopetrosis in mice lacking NF-kappaB1 and NF-kappaB2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2844-7

NF-kappaB p50 and p52 expression is not required for RANK-expressing osteoclast progenitor formation but is essential for RANK- and cytokine-mediated osteoclastogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2844-7

I{kappa}B kinase (IKK){beta}, but not IKK{alpha}, is a critical mediator of osteoclast survival and is required for inflammation-induced bone loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2844-7

Signal transduction by receptor activator of nuclear factor kappa B in osteoclasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2844-7

NF-kappa B activation in human breast cancer specimens and its role in cell proliferation and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2844-7

JNK1 modulates osteoclastogenesis through both c-Jun phosphorylation-dependent and -independent mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2844-7

10.1007/S10549-014-2844-7

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24481680%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

1 reference